Volume Buzzer: This Multibagger Pharma Stock Jumps 10%; Trading Volume Surges 8x Above 20-Day Average, FII Stake Increases
Join Us
Follow Us
Piramal Pharma witnessed strong buying interest on Tuesday, with trading volume surging to 348.8 lakh shares against its 20-day average volume of 43 lakh shares, while Foreign Institutional Investors increased their stake in the March 2026 quarter
✨ Key Takeaways
On Tuesday, Indian equity benchmarks traded higher, with the benchmark Nifty 50 index rising 0.09 per cent to 24,124.45. Amid the positive market sentiment, Piramal Pharma share price traded at Rs 174.06, up 9.81 per cent from the previous close. The stock also witnessed a sharp rise in trading activity, with volume of 348.8 lakh shares compared with its 20-day average volume of 43 lakh shares, indicating significantly higher investor participation.
FIIs Increase Stake In March Quarter
According to the latest shareholding pattern, Foreign Institutional Investors (FIIs) increased their stake in Piramal Pharma to 30.17 per cent in March 2026 from 29.66 per cent in December 2025, reflecting an increase of 0.51 percentage points. During the same period, Domestic Institutional Investors (DIIs) marginally reduced their holding to 15.61 per cent from 15.68 per cent. Promoter shareholding remained unchanged at 34.85 per cent, while public shareholding declined to 19.01 per cent from 19.35 per cent in the previous quarter.
Piramal Pharma Strong Trading Activity
The stock emerged among the notable gainers in the pharmaceutical space during the session. Trading volume was more than eight times its 20-day average volume, reflecting heightened investor interest. The sharp rise in volume alongside the price gain suggests strong market participation in the counter.
Piramal Pharma Share Price Performance
Piramal Pharma has delivered positive returns across multiple time periods. The stock has gained 2.90 per cent over the past one month, 2.11 per cent over the last six months and 10.31 per cent over the past year. The company currently has a market capitalisation of approximately Rs 23,219 crore.
Also Read - Rs 11,400 Crore Order Book: Railway Infrastructure Company Secures Rs 213 Crore Work Order For West Bengal Project
About Piramal Pharma
Piramal Pharma Ltd is a global pharmaceutical company with a presence across Contract Development and Manufacturing Organisation (CDMO), complex hospital generics and consumer healthcare businesses. The company serves pharmaceutical and healthcare customers across North America, Europe, Japan and emerging markets.
The company operates multiple manufacturing and development facilities globally and provides integrated solutions across the pharmaceutical value chain, including drug development, manufacturing and commercialisation. Piramal Pharma is a part of the Piramal Group and caters to both innovator and generic pharmaceutical companies.
Add DSIJ as your preferred news source on G o o g l e
Add NowWhat are your thoughts on Piramal Pharma's volume-led rally and rising FII ownership? Share your views in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.